Paper · 3698367
Restoration by recombinant interferon alpha A/D of host defense systems against tumor in immunosuppressed mice.
Nishimura J and 5 others. Clin Exp Metastasis, 1986. Cited by 7 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Restoration by recombinant interferon alpha A/D of host defense systems against tumor in immunosuppressed mice. Papers, record 3698367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3698367
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Restoration by recombinant interferon alpha A/D of host defense systems against tumor in immunosuppressed mice.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| G(M1) Ganglioside | Major topic |
| Interferon Type I | Major topic |
| Killer Cells, Natural | Major topic |
| Melanoma | Major topic |
| Recombinant Proteins | Major topic |
| Animals | |
| Antibodies | |
| Carrageenan | |
| Cyclophosphamide | |
| Glycosphingolipids | |
| Immunity, Innate | |
| Immunosuppression Therapy | |
| Mice | |
| Neoplasm Metastasis |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,180,004 | In vitro interactions of purified cloned human interferons on NK cells: enhanced activation. | J Immunol | 1982 | https://conductscience.org/library/papers/6180004 | PubMed |
| 2 | 712,067 | Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility. | J Immunol | 1978 | https://conductscience.org/library/papers/712067 | PubMed |
| 3 | 6,480,158 | Inhibition of experimentally-induced murine metastases by recombinant alpha interferon: correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases. | Int J Cancer | 1984 | https://conductscience.org/library/papers/6480158 | PubMed |
| 4 | 6,932,529 | Role of natural killer cells in the destruction of circulating tumor emboli. | J Natl Cancer Inst | 1980 | https://conductscience.org/library/papers/6932529 | PubMed |
| 5 | 3,841,037 | Antitumor and antimetastatic activities of human recombinant interferon alpha A/D. | Clin Exp Metastasis | 1985 | https://conductscience.org/library/papers/3841037 | PubMed |
| 6 | 3,886,826 | Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2. | J Exp Med | 1985 | https://conductscience.org/library/papers/3886826 | PubMed |
| 7 | 6,933,263 | Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice. | J Natl Cancer Inst | 1980 | https://conductscience.org/library/papers/6933263 | PubMed |
| 8 | 6,966,574 | A glycolipid on the surface of mouse natural killer cells. | Eur J Immunol | 1980 | https://conductscience.org/library/papers/6966574 | PubMed |
| 9 | 6,176,335 | Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes. | Cell Immunol | 1982 | https://conductscience.org/library/papers/6176335 | PubMed |
| 10 | 6,972,360 | Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural killer cell-mediated cytotoxicity. | Int J Cancer | 1980 | https://conductscience.org/library/papers/6972360 | PubMed |
1 to 10 of 20
See all 20 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 3,117,468 | Interferon-mediated enhancement of metastasis. Are MHC antigens involved? | Clin Exp Metastasis | 1987 | https://conductscience.org/library/papers/3117468 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNA1 | 3,439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IFNA2 | 3,440 | PubTator's text mining | https://conductscience.org/library/genes/3440 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3698367
GET https://conductscience.org/api/papers/v1/3698367/authors